Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
4 reports from 4 outlets in 1 language · first reported · updated · JSON
Reports
- Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal ForalumabPublished by manilatimes.net, GlobeNewswire — public companies ·
- Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trialproactiveinvestors.com · en ·
- Tiziana Begins Phase 2a BANYAN Trial Of Intranasal Foralumab In ALS Patientsrttnews.com · en ·